MBX
MBX Biosciences
116 hedge funds and large institutions have $836M invested in MBX Biosciences in 2025 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 29 increasing their positions, 30 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 30
47% less call options, than puts
Call options by funds: $15.3M | Put options by funds: $29M
Holders
116
Holding in Top 10
3
Calls
$15.3M
Puts
$29M
Top Buyers
| 1 | +$44.7M | |
| 2 | +$35M | |
| 3 | +$17.4M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$17M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$16.8M |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$6.86M | |
| 3 | -$6.1M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.06M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$4.31M |
